CYPRUMED Competitors and Similar CompaniesClear all

CYPRUMED's competitors and similar companies include Protagonist Therapeutics, Corbus Pharmaceuticals, Laurus Labs and Aepodia.

	CYPRUMED CYPRUMED is a drug delivery company developing a platform technology for the non-invasive delivery of biologics, with a focus on oral peptide delivery.	Protagonist Therapeutics Protagonist Therapeutics is a biopharmaceutical company engaged in discovering and developing peptide-based therapeutic drugs.	Corbus Pharmaceuticals Corbus Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company.	Laurus Labs Laurus Labs is a pharmaceutical company.	Aepodia Aepodia is a company specialized in the strategy and delivery of drugs and the development of medical devices.
Founding Date	Founding Date 2015	Founding Date 2006	Founding Date 2009	Founding Date 2005	Founding Date 2007
Type	Type Private	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare clinical research drug development pharma platform	Tags Healthcare biotech clinical research drug development pharma platform	Tags Healthcare clinical research drug development pharma	Tags Healthcare clinical research drug development pharma	Tags Healthcare clinical research drug development pharma
Locations	Locations Obsteig, AT HQ	Locations Newark, US HQ Saint Lucia, AU	Locations Norwood, US HQ	Locations Hyderabad, IN HQ Hamburg, DE Turkapally, IN Visakhapatnam, IN Visakhapatnam, IN Visakhapatnam, IN Visakhapatnam, IN see more	Locations Ottignies-Louvain-la-Neuve, BE HQ Villebon Sur Yvette, FR
Employees	Employees 5	Employees 12613% increase	Employees 14183% increase	Employees 5,75359% increase	Employees 6
Valuation ($)	Valuation ($) N/A	Valuation ($) 2.9 b	Valuation ($) 195.1 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $46m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₹68.1b (FY, 2026)	Revenue (est.) N/A
Net income	Net income N/A	Net income ($130.1m) (FY, 2025)	Net income ($78.5m) (FY, 2025)	Net income ₹8.9b (FY, 2026)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 28.3m	Total funding raised $ 12.7m	Total funding raised $ 90m	Total funding raised N/A